Lazard Asset Management
CABA icon

Lazard Asset Management’s Cabaletta Bio CABA Stock Holding History

Lazard Asset Management’s Portfolio CABA Stock Details CABA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-57
Closed – – 2323
2024
Q4 		$0 Hold
57
– – ﹤0.01% 2303
2024
Q3 		$0 Sell
57
-92
-62% -$532 ﹤0.01% 2278
2024
Q2 		$0 Sell
149
-2,001
-93% -$24.5K ﹤0.01% 2238
2024
Q1 		$35K Sell
2,150
-1,253
-37% -$26.9K ﹤0.01% 1788
2023
Q4 		$76K Buy
3,403
+118
+4% +$1.98K ﹤0.01% 1763
2023
Q3 		$49K Buy
3,285
+158
+5% +$2.16K ﹤0.01% 1865
2023
Q2 		$39K Buy
3,127
+100
+3% +$1.08K ﹤0.01% 1903
2023
Q1 		$24K Buy
3,027
+641
+27% +$6K ﹤0.01% 2009
2022
Q4 		$21K Buy
+2,386
New +$8.69K ﹤0.01% 2121

Other funds holding CABA

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
CF
Cantor Fitzgerald New York $6.78B AUM 29.01% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Lazard Asset Management's CABA Position: Q1 2025 in Review

Lazard Asset Management sold out of Cabaletta Bio (CABA) in Q1 2025, closing a stake of 57 shares.

Lazard Asset Management first reported a position in CABA in Q4 2022 and held it in 9 quarters. The position peaked at $76K in Q4 2023. 92 funds tracked by Wall St. Rank hold CABA as of Q1 2025.

  • Lazard Asset Management reported no remaining Cabaletta Bio position as of Q1 2025 after selling out during the quarter.
  • Lazard Asset Management sold 57 Cabaletta Bio shares in Q1 2025.
  • Lazard Asset Management first reported a position in Cabaletta Bio in Q4 2022 and held it in 9 quarters.
  • Lazard Asset Management's Cabaletta Bio position peaked at $76K in Q4 2023.
  • 92 funds tracked by Wall St. Rank held Cabaletta Bio as of Q1 2025.

Based on Lazard Asset Management's 13F filing for Q1 2025, filed 15 May 2025.